Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Terns Pharmaceuticals (TERN)
NASDAQ:TERN
RESEARCH TOOLSreports
Holding TERN?
Track your performance easily
Terns Pharmaceuticals (TERN) Ownership Overview
16.37% Insiders
7.60% Mutual Funds
1.44% Other Institutional Investors
8.47% ETFs
66.13% Public Companies and Individual Investors
The ownership structure of Terns Pharmaceuticals (TERN) stock is a mix of institutional, retail, and individual investors. Approximately 17.51% of the company’s stock is owned by Institutional Investors, 16.37% is owned by Insiders, and 66.13% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 17, 2024 | Hongbo Lu Director | xxxxxxxxxxxxx | $4999995 |
| Aug 05, 2024 | Jill M. Quigley Director | xxxxxxxxxxxxx | $47117 |
| Jul 17, 2024 | Carl Gordon Director, >10% Owner | xxxxxxxxxxxxx | $561640 |
| Jul 17, 2024 | Orbimed Advisors Llc Director, >10% Owner | xxxxxxxxxxxxx | $561640 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $61759 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $218662 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $5073749 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $5100662 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,237,329 | Insider | 7.39% | 46,530,474 | |
| 3,921,226 | Insider | 6.30% | 29,252,346 | |
| 3,293,235 | Institution | 3.90% | 24,567,533 | |
| 2,817,864 | Institution | 3.34% | 21,021,265 | |
| 1,825,586 | Institution | 2.16% | 13,618,872 | |
| 1,200,000 | Institution | 1.42% | 8,952,000 | |
| 1,083,905 | Institution | 1.28% | 8,085,931 | |
| 1,075,000 | Institution | 1.27% | 8,019,500 | |
| 901,224 | Institution | 1.07% | 6,723,131 | |
| 755,635 | Insider | 0.89% | 5,637,037 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,825,586 | Institution | 2.16% | 13,618,872 | |
| 1,200,000 | Institution | 1.42% | 8,952,000 | |
| 901,224 | Institution | 1.07% | 6,723,131 | |
| 641,945 | Institution | 0.76% | 4,788,910 | |
| 426,606 | Institution | 0.51% | 3,182,481 | |
| 394,157 | Institution | 0.47% | 2,940,411 | |
| 276,142 | Institution | 0.33% | 2,060,019 | |
| 156,411 | Institution | 0.19% | 1,166,826 | |
| 146,828 | Institution | 0.17% | 1,095,337 | |
| 118,982 | Institution | 0.14% | 887,606 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,085,766 | Institution | 2.47% | 17,395,288 | |
| 1,563,810 | Institution | 1.85% | 11,666,023 | |
| 683,251 | Institution | 0.81% | 5,698,313 | |
| 517,937 | Institution | 0.61% | 3,863,810 | |
| 415,958 | Institution | 0.49% | 3,103,047 | |
| 263,815 | Institution | 0.31% | 2,200,217 | |
| 165,792 | Institution | 0.20% | 1,210,282 | |
| 150,004 | Institution | 0.18% | 1,095,029 | |
| 137,497 | Institution | 0.16% | 1,003,728 | |
| 118,631 | Institution | 0.14% | 989,383 |
FAQ
Who Owns Terns Pharmaceuticals (TERN)?
According to the latest TipRanks data, approximately 1.44% of the company's stock is held by institutional investors, 16.37% is held by insiders, and 66.13% is held by retail investors.
What percentage of Terns Pharmaceuticals (TERN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.44% of Terns Pharmaceuticals (TERN) stock is held by institutional investors.
What percentage of Terns Pharmaceuticals (TERN) stock is held by retail investors?
According to the latest TipRanks data, approximately 66.13% of Terns Pharmaceuticals (TERN) stock is held by retail investors.
Who owns the most shares of Terns Pharmaceuticals (TERN)?
Vivo Opportunity, LLC owns the most shares of Terns Pharmaceuticals (TERN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.